Skip to content

Clinical trials

Muscular Dystrophy, Duchenne trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Dystrophy, Duchenne Country / region: Australia Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20082
20091
20103
20111
20121
20131
20142
20163
20173
20182
20191
20203
20212
20223
20233
20242
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated9
Active, not recruiting5
Unknown status2
Enrolling by invitation2
Recruiting2
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
PTC Therapeutics6
ReveraGen BioPharma, Inc.4
Cooperative International Neuromuscular Research Group3
NS Pharma, Inc.3
Pfizer3
Satellos Bioscience, Inc.3
Catabasis Pharmaceuticals2
Edgewise Therapeutics, Inc.2
GlaxoSmithKline2
Kyntra Bio2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Dystrophy, Duchenne40
Muscular Dystrophies13
Neuromuscular Diseases9
Musculoskeletal Diseases7
Genetic Diseases, Inborn5
Muscular Diseases5
Muscular Disorders, Atrophic5
Nervous System Diseases5
Genetic Diseases, X-Linked4
Osteoporosis2

Trials

Showing 76 to 40 of 40. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.